NeoGenomics announced three leadership appointments: Kathryn McKenzie as CFO, William Bonello as president of the informatics division, and Douglas Brown as chief strategy and corporate development officer. McKenzie was previously the VP of finance and chief accounting officer after joining NeoGenomics in 2017. She was also the assistant controller and director of financial reporting and treasury at Chico's FAS, and worked at Ernst and Young.
Bonello was previously the chief strategy and corporate development officer at NeoGenomics and will continue as director of investor relations, which he's been since 2018. Before joining NeoGenomics, he was a healthcare equity analyst at Craig-Hallum and senior VP for investor relations at Laboratory Corporation of America.
Brown is joining NeoGenomics from SVB Leerink, where he was senior managing director. He recently advised NeoGenomics on the acquisition of GenOptix and the oncology assets of Human Longevity.